Cargando…
Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis
BACKGROUND: Nasal hypersecretion due to idiopathic rhinitis can often not be treated sufficiently by conventional medication. Botulinum toxin A (BTA) has been injected into the nasal mucosa in patients with nasal hypersecretion with a reduction of rhinorrhea lasting for about 4 to 8 weeks. Since the...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770996/ https://www.ncbi.nlm.nih.gov/pubmed/19835591 http://dx.doi.org/10.1186/1746-160X-5-18 |